Biocon Ltd
Know More271.15↑4.25 (1.59%)
12:29 PM,29th Sep 2023271.25↑4.75 (1.78%)
12:41 PM,29th Sep 2023BSE : 532523
NSE : BIOCON
Sector : Health care
ISIN Code : INE376G01013
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Sep 29 2023 | 12:41 PM IST
| Market Cap (₹ Cr) | 32554 |
Turnover (₹ Cr) | 3.60 |
Volume (Shares) | 1328614 |
Face Value | 5 |
52-WK High | 299.15 |
52-WK High Date | 04 Oct 2022 |
52-WK Low | 191.55 |
52-WK Low Date | 21 Mar 2023 |
All Time High | 487.75 |
All Time High Date | 23 Dec 2020 |
All Time Low | 14.17 |
All Time Low Date | 02 Dec 2008 |
News
View MoreAnnouncement
View MoreBiocon Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 32554 |
| EPS - TTM (₹) [S] | 0.89 |
| P/E Ratio (X) [S] | 2.98 |
| Face Value (₹) | 5 |
| Latest Dividend (%) | 30.00 |
| Latest Dividend Date | 07 Jul 2023 |
| Dividend Yield (%) | 0.56 |
| Book Value Share (₹) [S] | 90.91 |
| P/B Ratio (₹) [S] | 2.98 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|---|---|---|
| SBI Multi Asset Allocation Fund (G) | 27.66 | 999318 | 1.51 |
| SBI Multi Asset Allocation Fund - Direct (G) | 27.66 | 999318 | 1.51 |
Research Reports
Stock Strength
| Today's Low/High | 265.10 271.75 |
| Week Low/High | 260.90 271.75 |
| Month Low/High | 256.95 280.00 |
| Year Low/High | 191.55 299.00 |
| All time Low/High | 14.42 488.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 2.73% | 2.57% | -0.07 | 0.01% |
| 1 Month | 4.65% | 4.63% | 1.37 | 1.73% |
| 3 Month | 10.67% | 10.67% | 3.21 | 3.71% |
| 6 Month | 34.00% | 33.90% | 14.49 | 16.08% |
| 1 Year | -5.49% | -5.47% | 16.94 | 17.00% |
| 3 Year | -40.52% | -40.47% | 73.71 | 75.34% |
Financials
- Financial Overview
- Income Statement
- Balance Sheet
- Profit & Loss
- Cash Flow Statement
- Ratios
- Revenue (Rs Cr)
- Net Profit (Rs Cr)
- Operating Profit (Rs Cr)
- Earnings Per Share(Rs)
- Book Value(Rs per share)
- Net Worth(Rs Cr)
- Divident(%)
- Dividend Payout(Rs Cr)
Bulk/ Block
| Date | Client Name | Exchange | Transaction | Quantity | Price |
|---|---|---|---|---|---|
| 17-03-2023 | AHAN - I LTD | NSE | SELL | 18928363 | 200.74 |
| 28-02-2023 | INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. | NSE | BUY | 8061599 | 229.26 |
| 14-11-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | NSE | SELL | 500049 | 281.05 |
| 14-11-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | NSE | BUY | 500049 | 281.05 |
| 03-11-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | NSE | SELL | 500049 | 268.45 |
| 03-11-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | NSE | BUY | 500049 | 268.45 |
| 25-10-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | BSE | SELL | 466252 | 270.10 |
| 25-10-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | BSE | BUY | 466252 | 270.10 |
| 17-10-2022 | ISHARES CORE EMERGING MARKETS MAURITIUS CO | BSE | SELL | 732649 | 261.30 |
| 17-10-2022 | ISHARES CORE MSCI EMERGING MARKETS ETF | BSE | BUY | 732649 | 261.30 |
Load More | |||||
Peer Group Comparison
- Ratio Performance
- Stock Performance
| Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
|---|
Shareholding Pattern
- Total shareholdings
| Category | Share(%) |
|---|---|
| Promoter | 60.64 |
| Financial Institutions Banks | 0.00 |
| Foreign Institutional Investors | 9.52 |
| Insurance Companies | 5.09 |
| Mutual Funds Uti | 7.47 |
| Other Institutional Investors | 0.03 |
| Indian Public | 13.34 |
| Others Non Institutional Investors | 3.42 |
| Custodians | 0.49 |
Corporate Action
| Announcement Date | Purpose | From | To | Remarks |
|---|---|---|---|---|
| Data Not Found |
Price History
Search for Price History
| Date | Open | High | Low | Close | Shares | Trades |
|---|---|---|---|---|---|---|
| Data Not Found |
Load more
Company Info
Company Information
Chairperson : Kiran Mazumdar Shaw
Director : Ravi Mazumdar
Independent Director : Vijay Kumar Kuchroo
Independent Director : M Damodaran
Independent Director : Bobby Parikh
Company Sec. & Compli. Officer : Mayank Verma
Managing Director & CEO : SIDDHARTH MITTAL
Director : Eric Vivek Mazumdar
Independent Director : Naina Lal Kidwai
Independent Director : Peter John Bains
Registered Office: 20th KM Hosur Road Hebbagodi, Electronic City P O,Bangalore,Karnataka-560100 Ph: 91-80-28082808
Email:co.secretary@biocon.com
